OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine
Ivan Urits, Matthew Borchart, Morgan Hasegawa, et al.
Pain and Therapy (2019) Vol. 8, Iss. 1, pp. 41-51
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Cannabidiol Adverse Effects and Toxicity
Marilyn A. Huestis, Renata Solimini, Simona Pichini, et al.
Current Neuropharmacology (2019) Vol. 17, Iss. 10, pp. 974-989
Open Access | Times Cited: 367

The Genomics ofCannabisand Its Close Relatives
Igor Kovalchuk, Marco Pellino, Philippe Rigault, et al.
Annual Review of Plant Biology (2020) Vol. 71, Iss. 1, pp. 713-739
Closed Access | Times Cited: 123

Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol
Patrícia Alves, Cristina Amaral, Natércia Teixeira, et al.
Pharmacological Research (2020) Vol. 157, pp. 104822-104822
Closed Access | Times Cited: 106

Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases
Dhanush Haspula, Michelle A. Clark
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7693-7693
Open Access | Times Cited: 100

Use of cannabidiol (CBD) for the treatment of chronic pain
Ivan Urits, Kyle Gress, Karina Charipova, et al.
Best Practice & Research Clinical Anaesthesiology (2020) Vol. 34, Iss. 3, pp. 463-477
Closed Access | Times Cited: 87

Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy
Giulia Abate, Daniela Uberti, Simone Tambaro
Biology (2021) Vol. 10, Iss. 6, pp. 542-542
Open Access | Times Cited: 71

Cannabidiol-Loaded Nanocarriers and Their Therapeutic Applications
Elham Assadpour, Atefe Rezaei, Sabya Sachi Das, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 487-487
Open Access | Times Cited: 23

Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence
Madison Wright, Patricia Di Ciano, Bruna Brands
Cannabis and Cannabinoid Research (2020) Vol. 5, Iss. 3, pp. 191-196
Open Access | Times Cited: 61

Current application of cannabidiol (CBD) in the management and treatment of neurological disorders
Brian Fiani, Kasra Sarhadi, Marisol Soula, et al.
Neurological Sciences (2020) Vol. 41, Iss. 11, pp. 3085-3098
Closed Access | Times Cited: 58

Cannabis Use and its Association with Psychological Disorders.
Ivan Urits, Kyle Gress, Karina Charipova, et al.
Psychopharmacology bulletin (2020) Vol. 50, Iss. 2, pp. 56-67
Closed Access | Times Cited: 54

Cannabis and pain: a scoping review
Camila Pantoja‐Ruiz, Paula Restrepo-Jiménez, Camilo Castañeda‐Cardona, et al.
Brazilian Journal of Anesthesiology (English Edition) (2021) Vol. 72, Iss. 1, pp. 142-151
Open Access | Times Cited: 49

Differentiating Cannabis Products: Drugs, Food, and Supplements
Arash Salehi, Keely Puchalski, Yalda Shokoohinia, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33

The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms
Fatma Haddad, Ghadeer Dokmak, Rafik Karaman
Life (2022) Vol. 12, Iss. 5, pp. 682-682
Open Access | Times Cited: 29

An Individuality of Response to Cannabinoids: Challenges in Safety and Efficacy of Cannabis Products
Sarunya Kitdumrongthum, Dunyaporn Trachootham
Molecules (2023) Vol. 28, Iss. 6, pp. 2791-2791
Open Access | Times Cited: 19

Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance
Stefano De Martini, Alessandra Gemma, Marco Ferrari, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3125-3125
Open Access | Times Cited: 16

The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis
Zaid H. Maayah, Shingo Takahara, Mourad Ferdaoussi, et al.
Inflammation Research (2020) Vol. 69, Iss. 6, pp. 549-558
Closed Access | Times Cited: 43

Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia
Amnon A. Berger, Joseph Keefe, Ariel Winnick, et al.
Best Practice & Research Clinical Anaesthesiology (2020) Vol. 34, Iss. 3, pp. 617-631
Closed Access | Times Cited: 43

Considerations and Implications of Cannabidiol Use During Pregnancy
Syena Sarrafpour, Ivan Urits, Jordan Powell, et al.
Current Pain and Headache Reports (2020) Vol. 24, Iss. 7
Closed Access | Times Cited: 41

Chitosan-based films with cannabis oil as a base material for wound dressing application
Dorota Chełminiak-Dudkiewicz, Aleksander Smolarkiewicz-Wyczachowski, Kinga Mylkie, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 26

Historical Perspectives and Overview of the Value of Herbal Medicine
Sylvester Chibueze Izah, Odangowei Inetiminebi Ogidi, Matthew Chidozie Ogwu, et al.
Reference series in phytochemistry (2023), pp. 1-33
Closed Access | Times Cited: 15

A semi-naturalistic open-label study examining the effect of prescribed medical cannabis use on simulated driving performance
Brooke Manning, Thomas R. Arkell, Amie C. Hayley, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 3, pp. 247-257
Open Access | Times Cited: 5

Cannabinoids in the Management of Acute Pain: A Systematic Review and Meta-analysis
Aaron Gazendam, Nicholas Nucci, Kyle Gouveia, et al.
Cannabis and Cannabinoid Research (2020) Vol. 5, Iss. 4, pp. 290-297
Open Access | Times Cited: 38

Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model
Vanessa Mitchell, Juliette Cornelia Harley, Sherelle L. Casey, et al.
Neuropharmacology (2021) Vol. 189, pp. 108529-108529
Closed Access | Times Cited: 31

Page 1 - Next Page

Scroll to top